Chemical inhibitors of MRP-L19 act through various mechanisms to inhibit the protein's function within the mitochondrial ribosome. Cycloheximide is known to interfere with the translocation step during protein synthesis, which directly affects the assembly and functionality of MRP-L19 by preventing its incorporation into the mitochondrial ribosome complex. Similarly, Chloramphenicol and Erythromycin target the 50S subunit of the mitochondrial ribosome, inhibiting peptidyl transferase activity and translocation of peptides, respectively, which are critical steps in the protein synthesis process where MRP-L19 plays a role. Tetracycline, by binding to the 30S subunit, prevents aminoacyl-tRNAs from attaching to the ribosome, thereby hindering the synthesis of proteins including MRP-L19.
Puromycin, an analog of aminoacyl-tRNA, causes premature chain termination by being erroneously incorporated into the growing peptide chain, which leads to the interruption of MRP-L19 synthesis. Dactinomycin, by intercalating into DNA, blocks mRNA synthesis necessary for MRP-L19 production. Anisomycin and Sparsomycin both target peptidyl transferase activity within the mitochondrial ribosome, but through distinct binding mechanisms, leading to an inhibition of protein synthesis which includes the production of MRP-L19. Ricin, although more commonly associated with the cytoplasmic ribosome, inactivates the larger 60S subunit by modifying the 28S rRNA, which can indirectly affect the synthesis of proteins that are crucial for the mitochondrial ribosome's structure and function, including MRP-L19. Fusidic acid prevents the dissociation of elongation factor G from the ribosome, which is a necessary step for subsequent protein synthesis cycles, thus impacting the synthesis of MRP-L19. Omura peptide hampers the GTPase activity of elongation factors by binding to the 50S subunit, which can lead to a general inhibition of protein synthesis that encompasses MRP-L19. Lastly, Linezolid impedes the formation of the 70S initiation complex by its interaction with the 23S rRNA, which is fundamental for the mitochondrial ribosome's operation and therefore affects the synthesis of MRP-L19 within the mitochondria.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Cycloheximide inhibits protein biosynthesis in eukaryotic organisms by interfering with the translocation step in protein synthesis, thus potentially reducing the functional pool of MRP-L19 by preventing its assembly into mitochondrial ribosomes. | ||||||
Chloramphenicol | 56-75-7 | sc-3594 | 25 g | $53.00 | 10 | |
Chloramphenicol acts by binding to the 50S subunit of the mitochondrial ribosome, which can inhibit the peptidyl transferase activity. This action can block the mitochondrial protein synthesis, thereby functionally inhibiting MRP-L19 which is part of the mitochondrial ribosome. | ||||||
Tetracycline | 60-54-8 | sc-205858 sc-205858A sc-205858B sc-205858C sc-205858D | 10 g 25 g 100 g 500 g 1 kg | $62.00 $92.00 $265.00 $409.00 $622.00 | 6 | |
Tetracycline binds to the 30S subunit of the mitochondrial ribosome, inhibiting the binding of aminoacyl-tRNAs. This can prevent the incorporation of amino acids into elongating peptide chains, hence inhibiting the synthesis of proteins including MRP-L19. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $163.00 $316.00 | 436 | |
Puromycin causes premature chain termination during protein synthesis by acting as an analog of aminoacyl-tRNA, which can lead to the inhibition of mitochondrial protein translation, including the synthesis of MRP-L19. | ||||||
Erythromycin | 114-07-8 | sc-204742 sc-204742A sc-204742B sc-204742C | 5 g 25 g 100 g 1 kg | $56.00 $240.00 $815.00 $1305.00 | 4 | |
Erythromycin binds to the 50S subunit of the mitochondrial ribosome, leading to the inhibition of translocation of peptides from the A site to the P site, which can inhibit the synthesis of mitochondrial proteins, including MRP-L19. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Dactinomycin intercalates into DNA, preventing RNA synthesis, which can reduce the availability of mRNA for mitochondrial protein synthesis and thereby functionally inhibit the production of MRP-L19 without affecting transcription. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin interferes with protein synthesis by inhibiting peptidyl transferase activity in the mitochondrial ribosome, which can lead to inhibition of mitochondrial protein synthesis including the synthesis of MRP-L19. | ||||||
Fusidic acid | 6990-06-3 | sc-215065 | 1 g | $292.00 | ||
Fusidic acid prevents the turnover of elongation factor G (EF-G) from the ribosome, which can lead to inhibition of protein synthesis including the mitochondrial ribosome-associated protein MRP-L19. | ||||||
Thiostrepton | 1393-48-2 | sc-203412 sc-203412A | 1 g 5 g | $115.00 $415.00 | 10 | |
Omura peptide, also known as thiostrepton, binds to the 50S subunit and inhibits the GTPase activity of elongation factors, which can inhibit protein synthesis in mitochondrial ribosomes, thereby inhibiting the function of MRP-L19. | ||||||